- Kaasch AJ, et al.: Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 2014; 68: 242–51.
- Lopes-Cortes L,et al.: Impact of an evidence- based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 2013; 57: 1125–33.
- Fries BL, et al.: Infectious diseases consultation and the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2014; 58: 598–9.
- Thwaites GE, et al.: Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis 2011; 11: 208–22.
- Holland TL, et al.: Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 2014; 312: 1330–41.
- Levy MM, et al.: Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012; 12: 919–24.
- Kumar A, et al.: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589–96.
- Dellinger RP, et al.: Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock. Crit Care Med 2013; 41: 580–637.
- S-2k Leitlinie AWMF-Register-Nr. 079/001: Sepsis – Diagnose, Prävention, Therapie und Nachsorge (2010).
- Bödeker B, et al.: Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health 2015; 15: 1–10.
- Uyeki TM: Preventing and controlling influenza with available interventions. NEJM 2014; 370: 789–91.
- Empfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut/ Stand: August 2015: Epidemiol Bulletin 2015; 34: 327–62.
- influenza.rki.de/Wochenberichte/ 2015_2016/2015–41.pdf (letzter Zugriff: 18. 10. 2015).
- www.flunewseurope.org/ (letzter Zugriff: 18. 10. 2015).
- www.impfen-info.de (letzter Zugriff: 18. 10. 2015).
- Mina MJ, et al.: Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015; 348: 694–9.
- Demicheli V, et al.: Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev, 2012; 15, DOI: 10.1002/14651858.CD004407.pub3.
- Überblick über die Epidemiologie der Masern in 2014 und aktuelle Situation in 2015 in Deutschland: Epidemiol Bulletin 2015; 10: 69–79.
- www.measlesrubellainitiative.org/ (letzter Zugriff 15. 10. 2015).
- www.who.int/mediacentre/factsheets/ fs286/en/ (letzter Zugriff 15. 10. 2015).
- MacGregor RR, Graziani AL: Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis 1997; 24: 457–67.
- Nathwani D, et al.: Implementing criteriabased early switch/early discharge programmes: a European perspective. Clin Microbiol Infect 2015; 21: S47–55.
- S3 Leitlinie AWMF-Register-Nr. 092/001: Strategie zur Sicherung rationaler Antibiotika- Anwendung im Krankenhaus (2013).
- S3 Leitlinie AWMF-Register-Nr. 082/001: Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen tiefen Atemwegsinfektionen (akute Bronchitis, akute Exazerbation einer chronischen Bronchitis, Influenza und andere respiratorische Virusinfektionen) sowie ambulant erworbener Pneumonie (2009).
- Shapiro DJ, et al.: Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. J Antimicrob Chemother 2014; 69: 234–40.
- Barnett ML, Linder JA: Antibiotic prescribing for adults with acute bronchitis in the United States, 1996–2010. JAMA 2014; 311: 2020–2.
- Little P, et al.: Amoxicillin for acute lowerrespiratory- tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Inf Dis 2013; 13: 123–9.
- Hersh AL, et al.: American Academy of Pediatrics Committee on Infectious Diseases. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics 2013; 132: 1146–54
- S3 Leitlinie DEGAM-Nr. 11. Husten (2014).
- Zalmanovici TA, Lador A, Sauerbrun-Cutler MT, et al.: Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev 2015, DOI: 10.1002/ 14651858.CD009534.pub2.
- Weiskopf J, Scott S: Asymptomatic bacteriuria, what are you treating? JAMA internal medicine 2015; 175: 344–5.
- Nicolle LE: Management of asymptomatic bacteriuria in pregnant women. Lancet Infect Dis 2015, DOI: 10.1016/S1473–3099(15)00145–0.
- Coussement J, Abramowicz D: Should we treat asymptomatic bacteriuria after renal transplantation? Nephrology, dialysis, transplantation 2014; 29: 260–2.
- S3 Leitlinie DEGAM-Nr. 1. Brennen beim Wasserlassen (2009).
- S3 Leitlinie AWMF-Register-Nr. 043/044. Epidemiologie, Diagnostik, Therapie und Management unkomplizierter bakterieller ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten (2010).
- Meersseman W, Lagrou K, Spriet I, et al.: Significance of the isolation of candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009; 35: 1526–31.
- Lindau S, et al.: Antifungal therapy in patients with pulmonary Candida spp. Colonization may have no beneficial effects. Journal of Intensive Care 2015; 31: 1–9.
- Cornely OA, Bassetti M, Calandra T, et al.: ESCMID* guideline for the diagnosis and management of Candida diseases 012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18: 19–37.
- PEG-Empfehlungen: „Perioperative Antibiotikaprophylaxe“, 2010.
- S1 Leitlinie AWMF-Register Nr. 029/ 022. Perioperative Antibiotikaprophylaxe (2012).
- Bratzler DW, et al.: Clinical practice guidelines for antimicrobial prophylaxis in surgery, Am J Health-Syst Pharm 2013; 70: 195–283.
- ten Oever J, et al.: Utility of immune response- derived biomarkers in the differential diagnosis of inflammatory disorders. J Infect 2015; Sep 30. DOI: 10.1016/j.jinf.2015.09.007.
- Galarraga B, et al.: C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology 2008; 47: 1780–4.
- Auer J, et al.: C-reactive protein in patients with acute myocardial infarction. Circulation. 2004; 109: E20.
- Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–54.